MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 264 filers reported holding MYRIAD GENETICS INC in Q1 2019. The put-call ratio across all filers is 2.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,269,000 | -21.8% | 118,456 | -8.5% | 1.83% | -19.5% |
| Q3 2021 | $4,179,000 | +2.6% | 129,411 | -2.8% | 2.27% | +4.9% |
| Q2 2021 | $4,072,000 | -27.0% | 133,171 | -27.3% | 2.17% | -32.5% |
| Q1 2021 | $5,576,000 | +50.3% | 183,121 | -2.4% | 3.21% | +18.3% |
| Q4 2020 | $3,711,000 | +46.7% | 187,636 | -3.3% | 2.72% | +8.5% |
| Q3 2020 | $2,529,000 | +34.0% | 193,970 | +16.5% | 2.50% | +6.1% |
| Q2 2020 | $1,887,000 | -19.9% | 166,441 | +1.1% | 2.36% | -37.7% |
| Q1 2020 | $2,356,000 | -52.2% | 164,651 | -9.1% | 3.79% | -3.9% |
| Q4 2019 | $4,930,000 | +0.2% | 181,040 | +5.4% | 3.94% | -5.9% |
| Q3 2019 | $4,920,000 | +10.4% | 171,834 | +7.1% | 4.19% | +7.4% |
| Q2 2019 | $4,457,000 | +36.7% | 160,434 | +63.4% | 3.90% | +34.5% |
| Q1 2019 | $3,260,000 | +836.8% | 98,199 | +720.4% | 2.90% | +641.7% |
| Q4 2018 | $348,000 | -91.8% | 11,970 | -87.0% | 0.39% | -88.4% |
| Q3 2018 | $4,230,000 | -7.5% | 91,948 | -24.9% | 3.37% | -4.7% |
| Q2 2018 | $4,574,000 | +26.4% | 122,398 | -0.0% | 3.54% | +6.6% |
| Q1 2018 | $3,618,000 | -15.3% | 122,428 | -1.5% | 3.32% | -9.4% |
| Q4 2017 | $4,270,000 | -53.0% | 124,338 | -50.5% | 3.67% | -53.1% |
| Q3 2017 | $9,086,000 | +31.9% | 251,143 | -5.8% | 7.81% | +22.9% |
| Q2 2017 | $6,886,000 | +20.7% | 266,493 | -10.3% | 6.36% | +28.4% |
| Q1 2017 | $5,706,000 | +77.3% | 297,168 | +53.9% | 4.95% | +97.2% |
| Q4 2016 | $3,219,000 | -19.4% | 193,095 | -0.5% | 2.51% | -26.8% |
| Q3 2016 | $3,993,000 | +28.2% | 194,015 | +90.6% | 3.43% | +13.1% |
| Q2 2016 | $3,115,000 | -22.6% | 101,790 | -5.3% | 3.03% | -21.1% |
| Q1 2016 | $4,022,000 | -21.9% | 107,457 | -9.9% | 3.84% | -4.8% |
| Q4 2015 | $5,149,000 | -2.8% | 119,290 | -15.6% | 4.04% | -18.3% |
| Q3 2015 | $5,300,000 | +8.5% | 141,410 | -1.6% | 4.95% | +29.7% |
| Q2 2015 | $4,883,000 | -5.9% | 143,659 | -2.0% | 3.81% | -2.1% |
| Q1 2015 | $5,191,000 | +5.9% | 146,650 | +1.9% | 3.90% | -3.6% |
| Q4 2014 | $4,902,000 | -51.6% | 143,910 | -45.2% | 4.04% | -45.6% |
| Q3 2014 | $10,136,000 | – | 262,785 | – | 7.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
| Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
| RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
| RK Capital | 384,900 | $16,612,000 | 2.90% |
| Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
| S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
| Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
| AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
| Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
| KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |